惠泰医疗2025年度归母净利润8.21亿元，同比增长21.91%

Core Insights - Huatai Medical (688617.SH) reported a revenue of 2.584 billion yuan for the year 2025, representing a year-on-year growth of 25.08% [1] - The net profit attributable to the parent company's owners reached 821 million yuan, with a year-on-year increase of 21.91% [1] Performance Drivers - The company's continuous market expansion and various promotional activities have enhanced its operational advantages in R&D, technology, quality, market, and channels, leading to improved product coverage and hospital admission rates [1] - The company emphasizes cost control, focusing R&D and sales expenses on the market promotion, clinical validation, and iterative development of core products like PFA, optimizing expenditure structure and rhythm through refined operations and scaled operations, achieving synchronized growth in net profit and revenue [1]